Inventor · disambiguated record
Kenji Kawashima
Also filed as: KAWASHIMA KENJI
19 granted patents·1 pending application·38 citations·filing 2004–2019
91Inventor score
Files withSANTEN PHARMACEUTICAL CO LTD10HONDA TAKAHIRO3KAWASHIMA KENJI2MATSUDA MAMORU2AYUMI PHARMACEUTICAL CORP1
Top patents by PatentIndex Score
20 records- 0189US10435379B2[4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 8, 2019·5 cites·9 claims
- 0289US10189796B2[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 29, 2019·6 cites·26 claims
- 0380US7544703B2Cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced thereinSANTEN PHARMACEUTICAL CO LTD·Filed 2005·Granted Jun 9, 2009·8 cites·22 claims
- 0478US8017775B21-2-dihydroquinoline derivative having glucocorticoid receptor binding activitySANTEN PHARMACEUTICAL CO LTD·Filed 2006·Granted Sep 13, 2011·3 cites·35 claims
- 0578US7906511B2Cyclic compound having pyrimidinylalkylthio groupSANTEN PHARMACEUTICAL CO LTD·Filed 2006·Granted Mar 15, 2011·3 cites·6 claims
- 0677US8551991B21,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activityMATSUDA MAMORU·Filed 2007·Granted Oct 8, 2013·3 cites·17 claims
- 0773US9062061B2Compound having PARP inhibitory activityHONDA TAKAHIRO·Filed 2012·Granted Jun 23, 2015·4 cites·18 claims
- 0869US8445529B2Indole derivative having, carbamoyl group, ureido group and substituted oxy groupKAWASHIMA KENJI·Filed 2009·Granted May 21, 2013·1 cites·18 claims
- 0968US7977371B2Pyrrole derivative having ureido group and aminocarbonyl group as substituentsSANTEN PHARMACEUTICAL CO LTD·Filed 2008·Granted Jul 12, 2011·1 cites·23 claims
- 1067US8088817B2Pyrrole derivative having, as substituents, ureido group, aminocarbonly group and bicyclic group which may have substituentKAWASHIMA KENJI·Filed 2009·Granted Jan 3, 2012·1 cites·11 claims
- 1165US8193237B2Indole derivative having IκB kinase β inhibitory activityENOMOTO HIROSHI·Filed 2008·Granted Jun 5, 2012·1 cites·24 claims
- 1265US7534802B2Compounds having 4-pyridylalkylthio group as substituentSANTEN PHARMACEUTICAL CO LTD·Filed 2004·Granted May 19, 2009·2 cites·12 claims
- 1363US2019359577A1[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1h-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1462US8207194B2Compounds having a 4-pyridylalkylthio group as a substituentHONDA TAKAHIRO·Filed 2009·Granted Jun 26, 2012·0 cites·7 claims
- 1553US8518973B2Compounds having 4-pyridylalkylthio group as a substituentHONDA TAKAHIRO·Filed 2012·Granted Aug 27, 2013·0 cites·14 claims
- 1651US8975256B21,2,3,4-tetrahydroquinoxaline compounds having glucocorticoid receptor binding activitySANTEN PHARMACEUTICAL CO LTD·Filed 2013·Granted Mar 10, 2015·0 cites·5 claims
- 1748US7897774B2Cyclic compound having quinolylalkylthio groupSANTEN PHARMACEUTICAL CO LTD·Filed 2007·Granted Mar 1, 2011·0 cites·6 claims
- 1846US8420635B2Method for preventing or treating a glucocorticoid receptor-related diseaseMATSUDA MAMORU·Filed 2011·Granted Apr 16, 2013·0 cites·34 claims
- 1940US8507485B2Cyclic compound having pyrimidinylalkylthio groupTAJIMA HISASHI·Filed 2011·Granted Aug 13, 2013·0 cites·5 claims
- 2033US11186588B26H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,2,4]triazepine derivativeAYUMI PHARMACEUTICAL CORP·Filed 2018·Granted Nov 30, 2021·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Kenji Kawashima files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →